Abstract
Background
The utility of dual-phase enhanced computerized tomography (CT) scan in distinguishing adrenal ganglioneuromas from lipid-poor adenomas has not been reported. We aimed to retrospectively compare dual-phase enhanced CT findings which were helpful in distinguishing adrenal ganglioneuromas from adrenal lipid-poor adenomas.
Methods
We estimated the dual-phase enhanced CT findings of 258 adrenal masses (42 ganglioneuromas, 216 lipid-poor adenomas) in 258 patients from July 2008 to July 2020 with ganglioneuromas and July 2016 to July 2020 with lipid-poor adenomas. The CT features between ganglioneuromas and lipid-poor adenomas were compared using independent two-sample t test, Mann–Whitney test, and ROC analysis.
Results
Significant differences were detected in CT value of unenhanced (CTU), CT value of arterial phase (CTA), CT value of venous phase (CTV), degree of enhancement in arterial phase, degree of enhancement in portal venous phase, age, tumor size [longest dimension, shortest dimension, mean dimension], shape, calcification between the ganglioneuroma and lipid-poor adenoma groups (P < 0.05). The results of receiver operating characteristics (ROC) analyses showed that areas under ROC curves of CTU, CTA and CTV were 0.713, 0.878, and 0.914, respectively. When the cut-off values were set at 22.5 HU, 51.5 HU, and 53.5 HU for CTU, CTA, and CTV, respectively, the three parameters had a sensitivity of 46.8%, 67.6%, and 88.0% and a specificity of 100%, 100%, and 88.1% in distinguishing ganglioneuromas from lipid-poor adenomas.
Conclusions
Dual-phase enhanced abdominal CT can exhibit some of the primary imaging characteristics of ganglioneuromas and lipid-poor adenomas used to distinguish between these two entities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Department of Radiology, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
2 Tongde Hospital of Zhejiang Province, Department of Radiology, Hangzhou, China (GRID:grid.417168.d) (ISNI:0000 0004 4666 9789)
3 Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Department of Radiology, Hangzhou, China (GRID:grid.415999.9) (ISNI:0000 0004 1798 9361)





